17-65053580-T-C

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_006572.6(GNA13):ā€‹c.432A>Gā€‹(p.Gln144=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0124 in 1,613,844 control chromosomes in the GnomAD database, including 154 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.0097 ( 5 hom., cov: 33)
Exomes š‘“: 0.013 ( 149 hom. )

Consequence

GNA13
NM_006572.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.01
Variant links:
Genes affected
GNA13 (HGNC:4381): (G protein subunit alpha 13) Predicted to enable D5 dopamine receptor binding activity; G-protein beta/gamma-subunit complex binding activity; and GTPase activity. Predicted to be involved in several processes, including Rho protein signal transduction; activation of phospholipase D activity; and multicellular organism aging. Predicted to act upstream of or within several processes, including branching involved in blood vessel morphogenesis; negative regulation of vascular associated smooth muscle cell migration; and negative regulation of vascular associated smooth muscle cell proliferation. Located in cytosol and nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 17-65053580-T-C is Benign according to our data. Variant chr17-65053580-T-C is described in ClinVar as [Benign]. Clinvar id is 789341.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.01 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00965 (1470/152326) while in subpopulation AMR AF= 0.024 (367/15292). AF 95% confidence interval is 0.022. There are 5 homozygotes in gnomad4. There are 685 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1470 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GNA13NM_006572.6 linkuse as main transcriptc.432A>G p.Gln144= synonymous_variant 2/4 ENST00000439174.7
GNA13NM_001282425.2 linkuse as main transcriptc.147A>G p.Gln49= synonymous_variant 2/4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GNA13ENST00000439174.7 linkuse as main transcriptc.432A>G p.Gln144= synonymous_variant 2/41 NM_006572.6 P1Q14344-1
GNA13ENST00000541118.1 linkuse as main transcriptc.147A>G p.Gln49= synonymous_variant 2/42 Q14344-2

Frequencies

GnomAD3 genomes
AF:
0.00964
AC:
1467
AN:
152208
Hom.:
5
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00297
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0239
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.00443
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0131
Gnomad OTH
AF:
0.00860
GnomAD3 exomes
AF:
0.0110
AC:
2756
AN:
251494
Hom.:
26
AF XY:
0.00998
AC XY:
1356
AN XY:
135922
show subpopulations
Gnomad AFR exome
AF:
0.00265
Gnomad AMR exome
AF:
0.0272
Gnomad ASJ exome
AF:
0.00387
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00327
Gnomad FIN exome
AF:
0.00508
Gnomad NFE exome
AF:
0.0127
Gnomad OTH exome
AF:
0.0121
GnomAD4 exome
AF:
0.0127
AC:
18619
AN:
1461518
Hom.:
149
Cov.:
30
AF XY:
0.0123
AC XY:
8939
AN XY:
727106
show subpopulations
Gnomad4 AFR exome
AF:
0.00191
Gnomad4 AMR exome
AF:
0.0256
Gnomad4 ASJ exome
AF:
0.00432
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00351
Gnomad4 FIN exome
AF:
0.00578
Gnomad4 NFE exome
AF:
0.0145
Gnomad4 OTH exome
AF:
0.00967
GnomAD4 genome
AF:
0.00965
AC:
1470
AN:
152326
Hom.:
5
Cov.:
33
AF XY:
0.00920
AC XY:
685
AN XY:
74480
show subpopulations
Gnomad4 AFR
AF:
0.00296
Gnomad4 AMR
AF:
0.0240
Gnomad4 ASJ
AF:
0.00317
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00207
Gnomad4 FIN
AF:
0.00443
Gnomad4 NFE
AF:
0.0131
Gnomad4 OTH
AF:
0.00851
Alfa
AF:
0.0105
Hom.:
2
Bravo
AF:
0.0111
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.0117
EpiControl
AF:
0.0121

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 16, 2018- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.8
DANN
Benign
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs41300618; hg19: chr17-63049698; API